13F Pro13F Pro

SEC Form 4 reporting owner

Lynx1 Capital Management LP

Lynx1 Capital Management LP has filed 11 Form 4 transactions reported between December 19, 2025 and October 26, 2026, as 10% owner of Korro Bio, Inc., 10% owner of Passage BIO, Inc. and 10% owner of TScan Therapeutics, Inc..

Name as filed: Lynx1 Capital Management LP

Follow Lynx1 Capital Management LP and get an alert on every new Form 4

Lynx1 Capital Management LP holds 1.6M shares of KRRO, worth $19.7M, 11.84% of the company.

As of their Oct 22, 2026 Form 4 (filed Oct 26, 2026) · the filing on SEC EDGAR · valued at the Nov 19, 2026 close of $12.15 · 13.7M shares outstanding on Nov 3, 2026

Lynx1 Capital Management LP holds 673,759 shares of PASG, worth $2.5M, 20.94% of the company.

As of their Jun 25, 2026 Form 4 (filed Jun 29, 2026) · the filing on SEC EDGAR · valued at the Nov 19, 2026 close of $3.72 · 3.2M shares outstanding on Nov 6, 2026

Lynx1 Capital Management LP holds at least 8.0M shares of TCRX, worth $1.1M, 3.08% of the company.

As of their Dec 23, 2025 Form 4 · the filing on SEC EDGAR · valued at the Nov 19, 2026 close of $0.1400 · 260.0M shares outstanding on Sep 30, 2026, weighted average, basic

Counted from the latest direct line and the latest indirect line that traded. Shares held through other trusts or entities that did not trade are not included yet, so the true holding can be larger.

Open-market buys, 24 mo
$1.3M
11 lines
Open-market sales, 24 mo
None
reported
Companies
3
with Form 4 filings
Latest transaction
Oct 26, 2026
transaction date

Roles and reported holdings

  • KRROKorro Bio, Inc.
    Mar 31, 2026 – Oct 26, 2026

    10% owner

    See footnote1,624,789 sh

    As of Oct 22, 2026 · Form 4

    Shares held, direct and indirect, KRRO, after each Form 4
    1.5M1.6M1.6MAug 6, 2026: 1.5M shares (Form 4)Oct 22, 2026: 1.6M shares (Form 4)Aug 6, 2026Oct 22, 2026
    FilingShares afterChange
    Oct 22, 20261.6M+80K
    Aug 6, 20261.5M—

    24 months: $969K bought

  • PASGPassage BIO, Inc.
    Jun 25, 2026

    10% owner

    See footnote673,759 sh

    As of Jun 25, 2026 · Form 4

    24 months: $206K bought

  • TCRXTScan Therapeutics, Inc.
    Dec 19, 2025 – Dec 23, 2025

    10% owner

    Indirect (latest line that moved)8,019,148 sh

    As of Dec 23, 2025 · Form 4

    24 months: $146K bought

How their buys did since

11 open-market purchases against today’s price: -19.1% on average, -4.1% weighted by dollars spent.

DatePaidReturn
Oct 26, 2026KRRO$11.75+3.4%now $12.15
Oct 23, 2026KRRO$12.11+0.4%now $12.15
Oct 22, 2026KRRO$11.04+10.1%now $12.15
Oct 22, 2026KRRO$9.68+25.6%now $12.15
Aug 10, 2026KRRO$13.19-7.9%now $12.15
Aug 6, 2026KRRO$11.40+6.6%now $12.15
Jun 25, 2026PASG$4.12-9.7%now $3.72
Mar 31, 2026KRRO$10.60+14.6%now $12.15
Dec 23, 2025TCRX$0.8989-84.4%now $0.1400
Dec 22, 2025TCRX$0.9000-84.4%now $0.1400
Dec 19, 2025TCRX$0.8989-84.4%now $0.1400

Each purchase at the price on its Form 4, against the latest trade or close, adjusted for stock splits. Past returns say nothing about future ones.

Transaction history

All 11 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Oct 26, 2026KRRO10% ownerOpen-market purchaseCode P · indirect25,124$295K@ $11.75Form 4
Oct 23, 2026KRRO10% ownerOpen-market purchaseCode P · indirect2,510$30K@ $12.11Form 4
Oct 22, 2026KRRO10% ownerOpen-market purchaseCode P · indirect40,000$441K@ $11.04Form 4
Oct 22, 2026KRRO10% ownerOpen-market purchaseCode P · indirect12,175$118K@ $9.68Form 4
Aug 10, 2026KRRO10% ownerOpen-market purchaseCode P · indirect1,462$19K@ $13.19Form 4
Aug 6, 2026KRRO10% ownerOpen-market purchaseCode P · indirect5,222$60K@ $11.40Form 4
Jun 25, 2026PASG10% ownerOpen-market purchaseCode P · indirect50,055$206K@ $4.12Form 4
Mar 31, 2026KRRO10% ownerOpen-market purchaseCode P · indirect520$6K@ $10.60Form 4
Dec 23, 2025TCRX10% ownerOpen-market purchaseCode P · indirect6,232$6K@ $0.8989Form 4
Dec 22, 2025TCRX10% ownerOpen-market purchaseCode P · indirect75,500$68K@ $0.9000Form 4
Dec 19, 2025TCRX10% ownerOpen-market purchaseCode P · indirect80,069$72K@ $0.8989Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares each ownership line is left at by the person’s latest Form 4, 4/A or 5: held directly, and through each trust or entity named on the filing. A second class of common stock that converts into the listed one counts as shares; options and restricted stock units are listed but not counted. Value uses the latest trade or close, and the share of the company uses the latest shares-outstanding count the company reported. Where a filing has not yet been read line by line, the figure comes from the latest direct and indirect lines that traded and is shown as “at least”.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.